Literature DB >> 3181205

Lethal osteogenesis imperfecta: abnormal collagen metabolism and biochemical characteristics of hypophosphatasia.

P M Royce1, A Blumberg, R P Zurbrügg, A Zimmermann, J P Colombo, B Steinmann.   

Abstract

We have examined collagen from a patient with the rare type IIC form of perinatally lethal osteogenesis imperfecta, in whom biochemical characteristics of hypophosphatasia were also apparent. In addition to normal alpha 1(I) and alpha 2(I) chains, there were chains overmodified along their lengths. Unexpectedly, the thermal stability of molecules containing these chains was normal. This suggests the existence of a structural mutation causing delayed triple helix formation, situated in either the alpha 1(I) or alpha 2(I) C-terminal propeptide. Since collagen synthesised by fibroblasts from each of the patient's parents was normal, the mutation was probably newly arising and dominant. In contrast to other reported cases of lethal osteogenesis imperfecta, not only was the secretion of collagen by cultured fibroblasts considerably retarded, but that of non-collagenous proteins was also severely impaired.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181205     DOI: 10.1007/bf00442478

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

1.  Comparative studies on collagen glycosylation in chick skin and bone.

Authors:  P M Royce; M J Barnes
Journal:  Biochim Biophys Acta       Date:  1977-06-23

2.  Intron-mediated recombination may cause a deletion in an alpha 1 type I collagen chain in a lethal form of osteogenesis imperfecta.

Authors:  G S Barsh; C L Roush; J Bonadio; P H Byers; R E Gelinas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

3.  Observations on the heat-stability of alkaline phosphatase isoenzymes in serum.

Authors:  D W Moss; M J Shakespeare; D M Thomas
Journal:  Clin Chim Acta       Date:  1972-08       Impact factor: 3.786

4.  Collagen defects in lethal perinatal osteogenesis imperfecta.

Authors:  J F Bateman; D Chan; T Mascara; J G Rogers; W G Cole
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

5.  Analysis of cyanogen bromide peptides of type I collagen from a patient with lethal osteogenesis imperfecta.

Authors:  E Kirsch; R W Glanville; T Krieg; P Müller
Journal:  Biochem J       Date:  1983-06-01       Impact factor: 3.857

6.  Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.

Authors:  J F Bateman; T Mascara; D Chan; W G Cole
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

7.  Biochemical and morphological modifications in rabbit Achilles tendon during maturation and ageing.

Authors:  G Cetta; R Tenni; G Zanaboni; G De Luca; E Ippolito; C De Martino; A A Castellani
Journal:  Biochem J       Date:  1982-04-15       Impact factor: 3.857

8.  Hypophosphatasia (adult form): quantitation of serum alkaline phosphatase isoenzyme activity in a large kindred.

Authors:  J L Millán; M P Whyte; L V Avioli; W H Fishman
Journal:  Clin Chem       Date:  1980-06       Impact factor: 8.327

9.  Osteogenesis imperfecta: an expanding panorama of variants.

Authors:  D Sillence
Journal:  Clin Orthop Relat Res       Date:  1981-09       Impact factor: 4.176

10.  A reference method for measurement of alkaline phosphatase activity in human serum.

Authors:  N W Tietz; C A Burtis; P Duncan; K Ervin; C J Petitclerc; A D Rinker; D Shuey; E R Zygowicz
Journal:  Clin Chem       Date:  1983-05       Impact factor: 8.327

View more
  5 in total

1.  Brittle cornea syndrome: an heritable connective tissue disorder distinct from Ehlers-Danlos syndrome type VI and fragilitas oculi, with spontaneous perforations of the eye, blue sclerae, red hair, and normal collagen lysyl hydroxylation.

Authors:  P M Royce; B Steinmann; A Vogel; U Steinhorst; A Kohlschuetter
Journal:  Eur J Pediatr       Date:  1990-04       Impact factor: 3.183

2.  Biosynthesis of recombinant human pro-alpha 1(III) chains in a baculovirus expression system: production of disulphide-bonded and non-disulphide-bonded species containing full-length triple helices.

Authors:  M Tomita; N Ohkura; M Ito; T Kato; P M Royce; T Kitajima
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

Review 3.  Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.

Authors:  Michael P Whyte
Journal:  Nat Rev Endocrinol       Date:  2016-02-19       Impact factor: 43.330

Review 4.  Hypophosphatasia: an overview of the disease and its treatment.

Authors:  M L Bianchi
Journal:  Osteoporos Int       Date:  2015-08-06       Impact factor: 4.507

Review 5.  Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.

Authors:  S A Bowden; B L Foster
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.